Scarica l'app Stockscreener
93.86
2.69%
-2.59
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ILMN Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$96.45
Aprire:
$96.49
Volume 24 ore:
1.57M
Relative Volume:
0.91
Capitalizzazione di mercato:
$14.43B
Reddito:
$4.28B
Utile/perdita netta:
$1.26B
Rapporto P/E:
11.88
EPS:
7.9
Flusso di cassa netto:
$943.00M
1 W Prestazione:
-8.09%
1M Prestazione:
-1.71%
6M Prestazione:
+31.71%
1 anno Prestazione:
-34.71%
Intervallo 1D:
$91.65
$96.49
Intervallo di 1 settimana:
$91.65
$102.68
Portata 52W:
$68.70
$156.66
Illumina Inc Stock (ILMN) Company Profile
Nome
Illumina Inc
Settore
Industria
Telefono
(858) 202-4500
Indirizzo
5200 ILLUMINA WAY, SAN DIEGO, CA
Confronta ILMN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ILMN
Illumina Inc
|
93.86 | 14.82B | 4.28B | 1.26B | 943.00M | 7.90 |
|
TMO
Thermo Fisher Scientific Inc
|
524.80 | 201.90B | 43.21B | 6.58B | 6.17B | 17.28 |
|
DHR
Danaher Corp
|
202.46 | 146.42B | 24.01B | 3.41B | 4.86B | 4.7082 |
|
IDXX
Idexx Laboratories Inc
|
616.15 | 50.30B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
136.62 | 39.72B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
198.17 | 34.51B | 15.70B | 1.24B | 2.01B | 6.9036 |
Illumina Inc Stock (ILMN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-12 | Downgrade | Daiwa Securities | Outperform → Neutral |
| 2025-07-11 | Downgrade | Scotiabank | Sector Outperform → Sector Perform |
| 2025-03-04 | Reiterato | Citigroup | Neutral |
| 2025-02-28 | Downgrade | HSBC Securities | Buy → Hold |
| 2025-02-10 | Downgrade | Barclays | Equal Weight → Underweight |
| 2025-02-07 | Downgrade | TD Cowen | Buy → Hold |
| 2024-12-11 | Downgrade | Citigroup | Buy → Neutral |
| 2024-11-12 | Ripresa | Morgan Stanley | Equal-Weight |
| 2024-10-17 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2024-08-28 | Aggiornamento | Argus | Hold → Buy |
| 2024-08-16 | Aggiornamento | Daiwa Securities | Neutral → Buy |
| 2024-08-14 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2024-08-14 | Aggiornamento | TD Cowen | Hold → Buy |
| 2024-07-10 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-06-03 | Ripresa | Jefferies | Hold |
| 2024-01-16 | Downgrade | HSBC Securities | Buy → Hold |
| 2024-01-04 | Downgrade | TD Cowen | Outperform → Market Perform |
| 2023-12-18 | Aggiornamento | Scotiabank | Sector Perform → Sector Outperform |
| 2023-12-15 | Aggiornamento | Bernstein | Underperform → Mkt Perform |
| 2023-12-14 | Iniziato | Guggenheim | Buy |
| 2023-12-14 | Iniziato | Stephens | Overweight |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-12-12 | Downgrade | BofA Securities | Neutral → Underperform |
| 2023-12-11 | Aggiornamento | Citigroup | Sell → Neutral |
| 2023-11-10 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2023-09-28 | Iniziato | Bernstein | Underperform |
| 2023-07-05 | Ripresa | JP Morgan | Neutral |
| 2023-01-25 | Downgrade | Argus | Buy → Hold |
| 2023-01-05 | Iniziato | Scotiabank | Sector Perform |
| 2022-12-12 | Downgrade | Citigroup | Neutral → Sell |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-10-04 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2022-09-28 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2022-08-25 | Iniziato | Credit Suisse | Neutral |
| 2022-07-13 | Downgrade | Barclays | Equal Weight → Underweight |
| 2022-01-18 | Aggiornamento | Stifel | Hold → Buy |
| 2022-01-11 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2022-01-07 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2022-01-06 | Ripresa | Morgan Stanley | Equal-Weight |
| 2022-01-06 | Ripresa | Piper Sandler | Overweight |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-08-19 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2021-06-01 | Aggiornamento | Evercore ISI | Underperform → In-line |
| 2021-03-31 | Downgrade | Atlantic Equities | Overweight → Neutral |
| 2021-03-31 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2021-03-03 | Iniziato | Barclays | Underweight |
| 2020-12-22 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2020-12-17 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2020-10-13 | Downgrade | Guggenheim | Buy → Neutral |
| 2020-09-30 | Iniziato | Atlantic Equities | Overweight |
| 2020-09-29 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2020-09-22 | Downgrade | Stifel | Buy → Hold |
| 2020-09-22 | Downgrade | UBS | Buy → Neutral |
| 2020-09-21 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-09-21 | Downgrade | JP Morgan | Overweight → Neutral |
| 2020-09-09 | Iniziato | Morgan Stanley | Equal-Weight |
| 2020-08-07 | Downgrade | Evercore ISI | In-line → Underperform |
| 2020-08-07 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2020-07-07 | Downgrade | Guggenheim | Buy → Neutral |
| 2020-04-24 | Downgrade | Citigroup | Buy → Neutral |
| 2020-04-21 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-01-08 | Iniziato | Wells Fargo | Underweight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2020-01-02 | Downgrade | Evercore ISI | Outperform → In-line |
| 2019-11-15 | Iniziato | Stifel | Buy |
| 2019-10-25 | Iniziato | Guggenheim | Buy |
Mostra tutto
Illumina Inc Borsa (ILMN) Ultime notizie
10x Genomics, BioMarin Pharmaceutical, AMN Healthcare Services, Illumina, and Moderna Stocks Trade Down, What You Need To Know - TradingView
Precision Medicine Market Size Booms at 16.35% CAGR, Expected to Reach USD 463.11 Billion by 2034 - GlobeNewswire Inc.
Sentiment analysis tools applied to Illumina Inc.Market Activity Summary & Free High Return Stock Watch Alerts - newser.com
Can volume confirm reversal in Illumina Inc.2025 Short Interest & Comprehensive Market Scan Insights - newser.com
3,608 Shares in Illumina, Inc. $ILMN Bought by Allegiance Financial Group Advisory Services LLC - MarketBeat
Illumina Inc. stock momentum explainedOptions Play & Real-Time Volume Spike Alerts - newser.com
QRG Capital Management Inc. Has $711,000 Stock Holdings in Illumina, Inc. $ILMN - MarketBeat
Why Illumina (ILMN) is a Top Momentum Stock for the Long-Term - Yahoo Finance
Illumina Inc. stock trendline breakdown2025 Buyback Activity & Expert Approved Trade Ideas - newser.com
Illumina Inc. stock volume spike explainedWeekly Market Report & Reliable Price Breakout Alerts - newser.com
What data driven models say about Illumina Inc.’s future2025 Earnings Surprises & Real-Time Volume Trigger Notifications - newser.com
Illumina (NASDAQ:ILMN) Earns Sell (D+) Rating from Weiss Ratings - MarketBeat
Illumina, Inc. (ILMN): A Bull Case Theory - MSN
Is Illumina Inc. (ILU) stock positioned for secular growthIPO Watch & Community Verified Trade Signals - newser.com
Wealthcare Advisory Partners LLC Has $851,000 Position in Illumina, Inc. $ILMN - MarketBeat
Illumina’s SWOT analysis: genetic sequencing giant faces headwinds By Investing.com - Investing.com Australia
Celebrating milestones and the future of oncology in China - Illumina
Mirae Asset Global Investments Co. Ltd. Reduces Stake in Illumina, Inc. $ILMN - MarketBeat
Will Illumina (ILMN) Beat Estimates Again in Its Next Earnings Report? - sharewise.com
Illumina, Inc. Experiences Evaluation Revision Amidst Ongoing Market Challenges - Markets Mojo
Illumina (ILMN) Analyst Rating Update: Evercore ISI Lowers Price Target | ILMN Stock News - GuruFocus
Illumina (NASDAQ:ILMN) Price Target Lowered to $132.00 at Evercore ISI - MarketBeat
Ultima Genomics UG 100 platform vs. Illumina NovaSeq X Series whole-genome sequencing benchmarking - Illumina
Assessing Illumina’s Value After 6% Weekly Rally and New Cost-Cutting Initiative - Yahoo
Slow Capital Inc. Sells 23,118 Shares of Illumina, Inc. $ILMN - MarketBeat
Illumina, Inc. Experiences Revision in Its Stock Evaluation Amid Competitive Market Dynamics - Markets Mojo
Illumina Stock Forms Golden Cross, Signaling Potential Bullish Breakout - Markets Mojo
How to interpret RSI for Illumina Inc. stock2025 Big Picture & Real-Time Chart Breakout Alerts - newser.com
Will Illumina’s (ILMN) AI-Powered BioInsight Reshape Its Precision Medicine Strategy? - Yahoo Finance
United States RNA Sequencing Market Set to Revolutionize - openPR.com
Will Illumina Inc. (ILU) stock test record highs in 2025Buy Signal & Verified Swing Trading Watchlists - newser.com
Will Illumina Inc. stock benefit from commodity pricesTrade Signal Summary & Low Risk Entry Point Guides - newser.com
Is Illumina Inc. still worth holding after the dipQuarterly Growth Report & Technical Pattern Recognition Alerts - newser.com
Backtesting results for Illumina Inc. trading strategiesJuly 2025 Recap & High Accuracy Buy Signal Tips - newser.com
Will Illumina Inc. stock continue dividend increasesJuly 2025 Closing Moves & Momentum Based Trading Signals - newser.com
A Look at Illumina’s (ILMN) Valuation Following Analyst Skepticism on BioInsight and New Partnerships - Sahm
Legacy Trust Trims Stake in Illumina, Inc. $ILMN - MarketBeat
Can Illumina Inc. stock resist sector downturnsTrade Analysis Report & Free Low Drawdown Momentum Trade Ideas - newser.com
Robeco Institutional Asset Management B.V. Sells 354,433 Shares of Illumina, Inc. $ILMN - MarketBeat
Why Illumina Inc. stock is in analyst buy zoneJuly 2025 Closing Moves & Weekly Top Gainers Alerts - newser.com
4,321 Shares in Illumina, Inc. $ILMN Acquired by Greenwood Capital Associates LLC - MarketBeat
4,544 Shares in Illumina, Inc. $ILMN Purchased by Pure Financial Advisors LLC - MarketBeat
State of Alaska Department of Revenue Lowers Holdings in Illumina, Inc. $ILMN - Defense World
Illumina (ILMN) Is Up 7.7% After Launching AI-Focused BioInsight Unit for Drug Discovery Innovation - simplywall.st
ILMN Stock Set to Benefit From the Launch of New BioInsight Division - Yahoo Finance
Why Illumina Inc. stock could see breakout soonWatch List & Real-Time Volume Trigger Notifications - newser.com
Hardman Johnston Global Advisors LLC Raises Holdings in Illumina, Inc. $ILMN - MarketBeat
Greenleaf Trust Has $758,000 Stock Position in Illumina, Inc. $ILMN - MarketBeat
What consensus target says about Illumina Inc. (ILU) stock2025 Stock Rankings & Consistent Profit Alerts - newser.com
Genomics, Illumina team up to capture Asia-Pacific whole genome sequencing market - digitimes
Illumina (ILMN) Stock Falls on Barclays Underweight RatingNews and Statistics - IndexBox
Illumina Inc Azioni (ILMN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Illumina Inc Azioni (ILMN) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Thaysen Jacob | Chief Executive Officer |
May 12 '25 |
Buy |
80.88 |
6,500 |
525,732 |
77,540 |
| Thaysen Jacob | Chief Executive Officer |
May 13 '25 |
Buy |
80.84 |
5,850 |
472,942 |
83,390 |
0.17%
2.19%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):